Glimeshine MP 1mg/500mg/15mg Tablet
Marketer
Shinemax Pharma India Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimeshine MP 1mg/500mg/15mg Tablet
Metformin/glimepiride/pioglitazone 1mg/500mg/15mg tablets offer triple-action blood sugar management. This combination therapy, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, resulting in reduced blood glucose. Always adhere to your physician's prescribed dosage and regimen. Take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals elevates hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be assessed before treatment begins. Limit alcohol consumption to mitigate potential side effect risks.
Uses of Glimeshine MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimeshine MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Glimeshine MP 1mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Glimeshine MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimeshine MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Glimeshine MP 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Glimeshine MP 1mg/500mg/15mg Tablet works:
Glimeshine MP 1mg/500mg/15mg tablets combine the antidiabetic actions of glimepiride, metformin, and pioglitazone. This triple therapy offers enhanced blood sugar management when monotherapy or dual combinations prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimeshine MP 1mg/500mg/15mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimeshine MP 1mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimeshine MP 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimeshine MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. The medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimeshine MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimeshine MP 1mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimeshine MP 1mg/500mg/15mg Tablet :
Should you forget to take a Glimeshine MP 1mg/500mg/15mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimeshine MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently